J Cancer Prev.
2016 Dec;21(4):302-302. 10.15430/JCP.2016.21.4.302.
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- 2BioInfra, Inc., Seoul, Korea. cwkim@snu.ac.kr
- 3Department of Pathology, Korea Regional Bank, Keimyung University School of Medicine, Daegu, Korea.
- 4Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
- 5Department of Statistics, College of Natural Science, Seoul National University, Seoul, Korea.
- KMID: 2367569
- DOI: http://doi.org/10.15430/JCP.2016.21.4.302
Abstract
- In Table 2 and 3, cutoff values of RANTES, ApoA2, TTR, Svcam-1 (and sensitivity and specificity values accordingly) were wrongly marked.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer
- Diagnostic Usefulness of Simultaneous Measurement ofSerum Tumor Markers in Lung Cancer Patients
- Performances of CYFRA 21-1, Carcinoembryonic Antigen and Their Combination for Lung Cancer Diagnosis
- Prostatic Cancer Presenting as an Isolated Large Lung Mass
- Neuroendocrine immunoperoxidase markers to predict chemotherapy response in lung cancer patients
